Volume | 18 |
|
|||||
News | - | ||||||
Day High | Low High |
||||||
Day Low |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Oncology Institute Inc | TOIIW | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
0.0996 | 0.0996 |
Trades | Volume | Avg Volume | 52 Week Range |
---|---|---|---|
1 | 18 | - | 0.022 - 0.3699 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
09:17:27 | 18 | $ 0.085 | USD |
Oncology Institute Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
809.76M | 73.75M | - | 324.24M | -83.07M | -1.13 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Oncology Institute News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical TOIIW Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 0.167 | 0.172 | 0.075 | 0.1167719 | 40,924 | -0.0674 | -40.36% |
1 Month | 0.2101 | 0.2475 | 0.075 | 0.1205876 | 11,720 | -0.1105 | -52.59% |
3 Months | 0.2501 | 0.2975 | 0.075 | 0.1814475 | 12,945 | -0.1505 | -60.18% |
6 Months | 0.23 | 0.3699 | 0.075 | 0.1934899 | 7,696 | -0.1304 | -56.70% |
1 Year | 0.0789 | 0.3699 | 0.022 | 0.0974352 | 11,709 | 0.0207 | 26.24% |
3 Years | 1.775 | 1.775 | 0.022 | 0.5480494 | 17,396 | -1.68 | -94.39% |
5 Years | 1.775 | 1.775 | 0.022 | 0.5480494 | 17,396 | -1.68 | -94.39% |
Oncology Institute Description
The Oncology Institute Inc offers oncology services committed to improving cancer prevention, diagnosis, treatment, research, and education. The company provides services including infusion centres. In-house dispensary, Outpatient blood transfusion, Outpatient stem cell transplant, financia, counseling, clinical trials, comprehensive lab testing, and end-of-life counseling.The business operates in three operating segments dispensary, patients services and clinical trials and others. Key revenue is earned from providing patient services. |